Alexander, who holds undergraduate and graduate degrees in nuclear engineering from Poly, has had a long career in the energy industry. Most recently, he served as chief executive officer of Innovene, British Petroleum’s olefins and derivatives subsidiary. In that capacity, he oversaw Innovene’s $9 billion sale to the INEOS Group in 2005. Previously, he held various executive positions at BP in a career spanning more than two decades.
Founded in 2003 by a chemical engineering professor at the University of California at Berkeley, Amyris is dedicated to improving the world by leveraging breakthroughs in synthetic biology.